
- ≥99% by HPLC; lot-matched COA available
- Lot-matched certificate of analysis
- Ships next business day, tracked
Pentapeptide-18 (Leuphasyl)
D-Ala2 leucine-enkephalin analog for neurotransmitter-release models
- FormLyophilized powder, sealed glass vial
- Mol. weight569.65 g/mol
- Research areasNeurotransmitter-release models, contraction-associated assays and comparative cosmetic-peptide formulation
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Overview
Pentapeptide-18 is a synthetic five-residue peptide with sequence Tyr-D-Ala-Gly-Phe-Leu, also called Leuphasyl or [D-Ala2]leucine-enkephalin. Replacing the second residue with D-alanine fixes the stereochemical identity and differentiates it from ordinary leucine-enkephalin, whose native sequence is Tyr-Gly-Gly-Phe-Leu; the substitution therefore sits at the first of the two glycine positions and is a long-standing device in enkephalin structure–activity work for slowing aminopeptidase cleavage. The molecule is cataloged under CAS 64963-01-5 with formula C29H39N5O7 and molecular weight 569.65 g/mol.
Cosmetic-peptide research has examined Pentapeptide-18 in neurotransmitter-release and contraction-associated model systems, often beside Argireline, SNAP-8, Syn-AKE or Vialox. Those materials act through different proposed steps, so a useful study compares them under the same cell, tissue and vehicle conditions rather than grouping them as interchangeable “expression peptides.” Unlike the palmitoylated actives it is frequently benchmarked against, Pentapeptide-18 carries no lipid modification and behaves as an ordinary water-soluble small peptide, which changes both its formulation requirements and what can reasonably be expected of it in a permeation experiment.
Specifications
Identity
- CAS number
- 64963-01-5
- Molecular formula
- C29H39N5O7
- Molecular weight
- 569.65 g/mol
- Amino acid sequence
- Tyr-D-Ala-Gly-Phe-Leu-OH
- Chain length
- 5 residues
- Peptide class
- Synthetic enkephalin-related pentapeptide
Supply & purity
- Form
- Lyophilized powder, sealed glass vial
- Purity
- ≥99% by HPLC; lot-matched COA available
Additional detail
- Available size
- 200 mg
- Also known as
- Leuphasyl, Pentapeptide-18, [D-Ala2]leucine-enkephalin
- Research areas
- Neurotransmitter-release models, contraction-associated assays and comparative cosmetic-peptide formulation
- Storage
- −20 °C lyophilized; protect from light and moisture
Questions about Pentapeptide-18 (Leuphasyl)
What is the sequence of Pentapeptide-18?
The defined sequence is Tyr-D-Ala-Gly-Phe-Leu-OH. The D configuration of the second alanine is part of the identity and should be retained in analytical records and comparison materials.
Is Pentapeptide-18 the same as leucine-enkephalin?
It is closely related but not identical. Pentapeptide-18 is [D-Ala2]leucine-enkephalin; the D-alanine substitution changes conformation and enzymatic stability relative to the native all-L peptide.
How does it differ from Argireline or Syn-AKE?
The three compounds have different sequences and proposed targets. Pentapeptide-18 is enkephalin-related, Argireline is a SNAP-25-derived hexapeptide, and Syn-AKE is a modified diaminobutyroyl benzylamide compound. They should be separate product entities.
What purity documentation is available?
The peptide is released at ≥99% by reversed-phase HPLC, with a certificate of analysis matched to the product lot available. Mass confirmation should correspond to the D-Ala-containing free-acid form.
How should the vial be stored?
Keep lyophilized material at −20 °C, sealed and protected from light and moisture. Refrigerate short-term working solutions and use aliquots for longer study periods to limit repeated freeze–thaw exposure.
Related







